Anne L. Peters
#43,543
Most Influential Person Now
Researcher
Anne L. Peters's AcademicInfluence.com Rankings
Anne L. Peterscomputer-science Degrees
Computer Science
#5846
World Rank
#6169
Historical Rank
Machine Learning
#1749
World Rank
#1772
Historical Rank
Artificial Intelligence
#1981
World Rank
#2015
Historical Rank
Database
#3007
World Rank
#3135
Historical Rank
Download Badge
Computer Science
Anne L. Peters's Degrees
- PhD Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Anne L. Peters Influential?
(Suggest an Edit or Addition)According to Wikipedia, Anne Peters is a endocrinologist, diabetes expert, and professor of clinical medicine at the Keck School of Medicine of USC. She runs diabetes centers in well-served Beverly Hills and under-resourced East Los Angeles. She teaches physicians and people with diabetes around the world how to better treat the condition, through lifestyle, medications and technology.
Anne L. Peters's Published Works
Published Works
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2014) (2714)
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) (1934)
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (2013) (1520)
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes (2007) (1502)
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes (2011) (1360)
- The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) (975)
- Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association (2014) (747)
- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2015) (654)
- Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition (2015) (620)
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. (2021) (484)
- Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems (2011) (460)
- Exercise management in type 1 diabetes: a consensus statement. (2017) (458)
- A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. (1996) (394)
- Vitamin D Supplementation and Prevention of Type 2 Diabetes. (2019) (366)
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. (2021) (309)
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. (2016) (308)
- Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry (2014) (269)
- Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. (2013) (261)
- Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes (2017) (259)
- The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) (253)
- Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). (2013) (241)
- Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) (234)
- An overview of metformin in the treatment of type 2 diabetes mellitus. (1997) (233)
- Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. (2014) (223)
- Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience (1996) (219)
- Understanding the sources of diabetes distress in adults with type 1 diabetes. (2015) (218)
- Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. (1999) (212)
- Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. (2014) (211)
- Food and park environments: neighborhood-level risks for childhood obesity in east Los Angeles. (2007) (205)
- International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors (2019) (183)
- REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes (2017) (180)
- 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. (2021) (179)
- Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes (2014) (175)
- Impact of Intensive Lifestyle Intervention on Depression and Health-Related Quality of Life in Type 2 Diabetes: The Look AHEAD Trial (2014) (163)
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2022. (2021) (158)
- Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. (2016) (155)
- A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program. (2012) (151)
- Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes (2014) (149)
- Application of a Diabetes Managed Care Program: The feasibility of using nurses and a computer system to provide effective care (1998) (149)
- Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) (145)
- Long-Term Outcomes of a Web-Based Diabetes Prevention Program: 2-Year Results of a Single-Arm Longitudinal Study (2015) (143)
- Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study (2018) (135)
- Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. (2004) (133)
- Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations (2017) (132)
- Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). (2008) (131)
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. (2020) (123)
- Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (2013) (117)
- The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. (2002) (113)
- Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes (2015) (110)
- Incretin-based therapies: review of current clinical trial data. (2010) (108)
- HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study (2018) (106)
- Translating the Diabetes Prevention Program into an Online Social Network (2014) (106)
- Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. (2016) (106)
- Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group (2015) (97)
- The Role of Farmers’ Markets in Two Low Income, Urban Communities (2012) (97)
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. (2021) (96)
- Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group (2019) (96)
- 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022. (2021) (95)
- Protein and fat effects on glucose responses and insulin requirements in subjects with insulin-dependent diabetes mellitus. (1993) (95)
- Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group (2019) (94)
- 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes-2022. (2021) (89)
- Insulin plus a sulfonylurea agent for treating type 2 diabetes. (1991) (86)
- The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. (2020) (84)
- Insulin Pump Risks and Benefits: A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs (2015) (82)
- Diabetic Ketoacidosis With Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes (2016) (82)
- Diabetes distress is linked with worsening diabetes management over time in adults with Type 1 diabetes (2017) (81)
- 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. (2021) (79)
- Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. (2012) (78)
- An Alternative Approach to the Diagnosis of Diabetes With a Review of the Literature (1995) (77)
- The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes (2016) (74)
- Management of Preexisting Diabetes in Pregnancy: A Review (2019) (74)
- Clinical Relevance of Non-HDL Cholesterol in Patients With Diabetes (2008) (74)
- A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes (2017) (73)
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022. (2021) (72)
- Standardizing Clinically Meaningful Outcome Measures Beyond HbA 1 c for Type 1 Diabetes : A Consensus Report of the American Association of Clinical Endocrinologists (2017) (71)
- Let’s Empower and Prepare (LEAP): Evaluation of a Structured Transition Program for Young Adults With Type 1 Diabetes (2015) (69)
- Prevalence of depression in Type 1 diabetes and the problem of over‐diagnosis (2016) (66)
- Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance (2003) (66)
- Male anorgasmia treated with oxytocin. (2008) (66)
- Improving the clinical value and utility of CGM systems: issues and recommendations (2017) (65)
- Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update (2017) (64)
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol. (2018) (64)
- 16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022. (2021) (63)
- Depression in Adults in the T1D Exchange Clinic Registry (2014) (63)
- Need for Regulatory Change to Incorporate Beyond A1C Glycemic Metrics (2018) (63)
- The insulin resistance syndrome and coronary artery disease (2003) (63)
- An Intervention for Enhancing Compliance With Screening Recommendations for Diabetic Retinopathy: A bicoastal experience (1997) (63)
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. (2021) (63)
- Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: Results from the look AHEAD randomized trial (2012) (63)
- Continuous Glucose Monitoring Profiles in Healthy Non-Diabetic Participants: A Multicenter Prospective Study. (2019) (62)
- Challenges contributing to disrupted transition from paediatric to adult diabetes care in young adults with Type 1 diabetes (2014) (60)
- 13. Older Adults: Standards of Medical Care in Diabetes-2022. (2021) (59)
- Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes (2016) (59)
- Management of patients with diabetes by nurses with support of subspecialists. (1995) (58)
- 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. (2021) (58)
- Intensive Weight Loss Intervention in Older Individuals: Results from the Action for Health in Diabetes Type 2 Diabetes Mellitus Trial (2013) (57)
- Effects of various enteral feeding products on postprandial blood glucose response in patients with type I diabetes. (1992) (56)
- Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment (2017) (54)
- [Behçet's disease in Tunisia. Clinical study of 519 cases]. (2006) (54)
- Gender Differences in Stroke Care Decision-Making (2006) (52)
- 14. Children and Adolescents: Standards of Medical Care in Diabetes-2022. (2021) (50)
- Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program (2019) (49)
- Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial (2018) (49)
- T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes (2018) (49)
- Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study (2017) (49)
- The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial (2017) (46)
- Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes* (2004) (45)
- 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. (2021) (44)
- The relationship of social support with treatment adherence and weight loss in Latinos with type 2 diabetes (2016) (44)
- The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older (2016) (44)
- 12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022. (2021) (43)
- Bene fi ts of ModestWeight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes (2011) (43)
- A standard set of person‐centred outcomes for diabetes mellitus: results of an international and unified approach (2020) (42)
- Effect of a Comprehensive Nurse-Managed Diabetes Program: An HMO Prospective Study (1996) (41)
- Immigration Disparities in Cardiovascular Disease Risk Factor Awareness (2011) (40)
- Role of Continuous Glucose Monitoring in Diabetes Treatment (2018) (39)
- Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study (2018) (38)
- Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 Trials (2018) (37)
- The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors. (1998) (36)
- Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes (2000) (36)
- Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy (2012) (35)
- Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease (2016) (35)
- Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. (1996) (34)
- The Look AHEAD Trial: Bone Loss at 4-Year Follow-up in Type 2 Diabetes (2014) (34)
- Davidson's diabetes mellitus : diagnosis and treatment (2004) (33)
- Clinical and Psychosocial Outcomes of a Structured Transition Program Among Young Adults With Type 1 Diabetes. (2017) (32)
- Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study (2018) (31)
- Intensive Weight Loss Intervention and Cancer Risk in Adults with Type 2 Diabetes: Analysis of the Look AHEAD Randomized Clinical Trial (2020) (31)
- Objectively-assessed physical activity and weight loss maintenance among individuals enrolled in a lifestyle intervention (2017) (31)
- Continuous glucose monitoring pilot in low-income type 1 diabetes patients. (2013) (31)
- Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis (2015) (31)
- Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study (2018) (31)
- Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis (2013) (30)
- Four-Year Physical Activity Levels among Intervention Participants with Type 2 Diabetes. (2016) (30)
- Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes. (1989) (30)
- Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk (2009) (29)
- Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine. (2004) (27)
- Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes (2009) (27)
- 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2022. (2021) (26)
- Hypoglycemia in Older Adults with Type 1 Diabetes. (2016) (25)
- Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes. (2014) (24)
- Cardiovascular health: associations with race-ethnicity, nativity, and education in a diverse, population-based sample of Californians. (2013) (24)
- The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM (2020) (23)
- Do Experiences Consistent With a Medical-Home Model Improve Diabetes Care Measures Reported by Adult Medicaid Patients? (2014) (22)
- Summary of Revisions: Standards of Medical Care in Diabetes-2022. (2021) (20)
- Primary Care Medical Home Experience and Health-Related Quality of Life Among Adult Medicaid Patients with Type 2 Diabetes (2014) (20)
- Effect of Isocaloric Substitution of Chocolate Cake for Potato in Type I Diabetic Patients (1990) (20)
- Patient Perspectives on Peer Mentoring (2015) (19)
- Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study (2015) (19)
- Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts (2018) (19)
- Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH) (2019) (19)
- Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial (2015) (19)
- Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulin (2017) (18)
- POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY. (2017) (18)
- The challenge of blood glucose management in diabetic patients receiving enteral or parenteral nutrition. (1993) (18)
- Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial (2019) (17)
- A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. (2022) (17)
- Using thiazolidinediones: rosiglitazone and pioglitazone in clinical practice. (2001) (17)
- The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin (2021) (17)
- Fasciite avec éosinophilie (syndrome de Shulman) : à propos de 11 patients (2010) (16)
- Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines (2018) (16)
- Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term. (2012) (15)
- Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment (2021) (15)
- “We Are All Gonna Get Diabetic These Days” (2014) (15)
- Weight Loss Experiences of African American, Hispanic, and Non‐Hispanic White Men and Women with Type 2 Diabetes: The Look AHEAD Trial (2019) (15)
- Clinical practice in type 2 diabetes: After metformin and lifestyle, then what? (2009) (15)
- Weight Change 2 Years After Termination of the Intensive Lifestyle Intervention in the Look AHEAD Study (2020) (15)
- Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes. (2020) (14)
- Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes. (2020) (14)
- Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study (2019) (14)
- Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies (2020) (13)
- Diabetes Empowerment Council: Integrative Pilot Intervention for Transitioning Young Adults With Type 1 Diabetes (2018) (13)
- Trends in diabetes-related visits to US EDs from 1997 to 2007. (2012) (13)
- ImmunoDip®: An Improved Screening Method for Microalbuminuria (2004) (13)
- Toward Development of Psychosocial Measures for Automated Insulin Delivery (2016) (13)
- Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study. (2022) (13)
- Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study (2021) (12)
- Issue Information ‐ Table of Contents (2016) (12)
- The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey (2019) (11)
- Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults. (2017) (11)
- The clinical implications of insulin resistance. (2000) (11)
- Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes (2013) (10)
- Summaries of Symposia Conducted in Conjunction with the 19th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (2010) (10)
- Function and Emotion in Everyday Life with Type 1 Diabetes (FEEL-T1D): A fully remote intensive longitudinal study of blood glucose, function, and emotional well-being in adults with type 1 diabetes. (2021) (10)
- Keep metformin guidelines intact. (1999) (10)
- [Eosinophilic fasciitis (Shulman's disease): a case series of 11 patients]. (2010) (9)
- Do menopausal status and APOE4 genotype alter the long-term effects of intensive lifestyle intervention on cognitive function in women with type 2 diabetes mellitus? (2020) (9)
- Benefit of Continuous Glucose Monitoring (CGM) in Reducing Hypoglycemia is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. (2022) (8)
- Addition of Hydrolyzed Guar to Enteral Feeding Products in Type I Diabetic Patients (1996) (7)
- Association Between Change in Accelerometer-Measured and Self-Reported Physical Activity and Cardiovascular Disease in the Look AHEAD Trial. (2022) (7)
- Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data (2020) (7)
- Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) (7)
- Response to Comment on Wong et al. Real-Time Continuous Glucose Monitoring Among Participants in the T1D Exchange Clinic Registry. Diabetes Care 2014;37:2702–2709 (2015) (7)
- Glycohemoglobin assessment program: glycated hemoglobin and epidemiologic variables in patients with type 2 diabetes. (2002) (7)
- Use of sulfonylurea agents in older diabetic patients. (1990) (7)
- OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data (2019) (7)
- DO MENOPAUSAL STATUS AND APOE4 GENOTYPE ALTER THE LONG-TERM EFFECTS OF INTENSIVE LIFESTYLE INTERVENTION ON COGNITIVE FUNCTION IN WOMEN WITH TYPE 2 DIABETES MELLITUS? (2019) (7)
- GLP-1 Provoked Severe Hypoglycemia in an Individual With Type 2 Diabetes and a Benign Insulinoma (2014) (7)
- Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry (2015) (7)
- 37-OR: Racial and Socioeconomic Disparities in the Use of Newer Classes of Diabetes Medications (2020) (6)
- Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study. (2020) (6)
- The changing therapeutic armamentarium for patients with type 1 diabetes (2016) (6)
- Impact of the New National Cholesterol Education Program (NCEP) Guidelines on Patient Management (2003) (6)
- Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study. (2020) (6)
- Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1) (2018) (6)
- Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange. (2018) (6)
- Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus. (2000) (5)
- The Changing Definition of a Primary Care Provider (2018) (5)
- Characteristics of adult‐ compared to childhood‐onset type 1 diabetes (2020) (5)
- Design and patient characteristics of the randomized controlled trial TExT-MED + FANS A test of mHealth augmented social support added to a patient-focused text-messaging intervention for emergency department patients with poorly controlled diabetes. (2019) (5)
- History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial (2020) (5)
- Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange (2020) (5)
- Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (The European inTandem2 Study) (2018) (5)
- [Abdominal tuberculosis: a retrospective series of 90 cases]. (2011) (5)
- Treating diabetes: cardiovascular benefits of antidiabetes drugs. (2002) (5)
- The Principle of Uti Possidetis Juris (2014) (5)
- Do we really need continuous glucose monitoring? (2009) (5)
- Death and medicine: a personal account. (1990) (5)
- Short and longer term outcomes of a diabetes disease management program in underserved Latino patients* (2005) (4)
- A Physician's Place in the #MeToo Movement (2018) (4)
- Extended-Release Formulation and Medication Adherence (2019) (4)
- Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association (2022) (4)
- Treatment of poorly controlled type 2 diabetes. (1994) (4)
- Integration of Diabetes Technology in Clinical Practice. (2020) (4)
- [McDuffie hypocomplementemic urticarial vasculitis associated with Sjögren's syndrome]. (2010) (4)
- Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. (2022) (4)
- [Etiological profile of digital necrosis of the upper limbs: analysis of 25 cases]. (2010) (4)
- [Takayasu's arteritis associated with acute myeloblastic leukemia]. (2006) (4)
- Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial (2020) (4)
- The STEPP-UP Project—Designing Low Literacy Teaching Tools for Use of Devices in a Minority Population (2018) (3)
- The Evidence Base for Continuous Glucose Monitoring (2018) (3)
- Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium–Glucose Cotransporter 2 Inhibitor (2020) (3)
- 1424-P: Changes in Device Uptake and Glycemic Control among Pregnant Women with Type 1 Diabetes: Data from the T1D Exchange (2019) (3)
- Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes (2022) (3)
- Differences in fairness and trust between lean and corpulent men (2016) (3)
- Jaccoud's arthropathy in primary Sjögren's syndrome with benign hypergammaglobulinaemic purpura. (1993) (3)
- Treaty making power (2009) (3)
- The making of a computer scientist (2018) (3)
- Community-Based Solutions for Chronic Disease (2007) (3)
- Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes (2022) (3)
- Sulfonylureas in the treatment of type II diabetes (1995) (3)
- Not all long-acting insulins are the same. (2002) (3)
- A Retrospective Analysis of the Capacity Built through a Community-Based Participatory Research Project Addressing Diabetes and Obesity in South and East Los Angeles (2014) (2)
- Impact of Health Insurance Policy on Diabetes Management (2020) (2)
- Diagnosing diabetes in 2000 (2000) (2)
- 259-OR: Stem Cell–Derived, Fully Differentiated Islet Cells for Type 1 Diabetes (2022) (2)
- Diabetes Disease Management: Past, Present, and Future (2001) (2)
- Exercise in Patients with Type 1 and Type 2 Diabetes Mellitus (2014) (2)
- Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets (2018) (2)
- Consensus development conference on pramlintide in the management of type 1 and type 2 diabetes (2006) (2)
- Identification of appropriate patients for cardiometabolic risk management. (2007) (2)
- The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes. (2017) (2)
- [Behcet's disease in Maghreb: Behcet Maghreb study about 1460 cases]. (2009) (2)
- 769-P: Glycemic Outcomes in Adults with Type 2 Diabetes over 21 Weeks with the Omnipod 5 Automated Insulin Delivery System (2022) (2)
- Das subjektive internationale Recht (2011) (2)
- Effect of a Long-Term Behavioral Weight Loss Intervention on Nephropathy in Overweight or Obese Adults with Type 2 Diabetes: the Look AHEAD Randomized Clinical Trial (2015) (2)
- Changes in mood and health‐related quality of life in Look AHEAD 6 years after termination of the lifestyle intervention (2021) (2)
- Associations of Intensive Lifestyle Intervention in Type 2 Diabetes With Health Care Use, Spending, and Disability (2020) (2)
- Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: The SAGE study (2021) (2)
- Function and Emotion in Everyday Life With Type 1 Diabetes (FEEL-T1D): Protocol for a Fully Remote Intensive Longitudinal Study (2021) (2)
- Increased Time-in-Range with Sotagliflozin as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes as Demonstrated by 24-Week Continuous Glucose Monitoring (inTandem1, inTandem2) (2018) (2)
- Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study—A Contemporary Prediabetes Cohort (2018) (1)
- Safety and Tolerability of Vitamin D Supplementation in the Vitamin D and Type 2 Diabetes (D2d) Study – A Randomized Trial in Persons With Prediabetes (2021) (1)
- Function and Emotion in Everyday Life with Type 1 Diabetes (FEEL-T1D): A fully remote intensive longitudinal study of blood glucose, function, and emotional well-being in adults with type 1 diabetes (Preprint) (2021) (1)
- [Venous thromboembolism: What other risk factors in a North African population? A study of 276 cases]. (2017) (1)
- Specialized Technology Education for Pumps & Pens in Underserved Populations with Diabetes (STEPP-UP). (2021) (1)
- Diabetes and Cardiovascular Disease Risk Factors as Influenced by Race and Ethnic Background (2015) (1)
- Rethinking Rates of Undiagnosed Diabetes: The Value of a Confirmatory Test (2017) (1)
- 1629-P: Association of Patient-Reported Outcomes (PROs) Scores with Glycemic Target Achievement in Type 1 Diabetes (T1D) in the SAGE Study (2020) (1)
- Managing Diabetes in the Middle-Aged Patient When Loss of Glycemic Control Occurs (2012) (1)
- Incident diabetes complications among women with type 1 diabetes based on parity (2020) (1)
- Increasing Patient Acceptance and Adherence Toward Insulin (2016) (1)
- The Importance of Having Rights (2021) (1)
- Comparative effectiveness research and formulary placement: the case of diabetes. (2013) (1)
- National Report: Switzerland (2012) (1)
- Remedies against Immunity? (2021) (1)
- Psychosocial and Behavioral Correlates of A1C and Quality of Life Among Young Adults With Diabetes (2018) (1)
- Rings of green (1982) (1)
- Dapagliflozin plus Saxagliptin Add-On vs. Glimepiride Add-On to Metformin in Patients with Poorly Controlled Type 2 Diabetes (2018) (1)
- Exercise in adults with type 1 diabetes mellitus (2022) (1)
- Therapy of Type 1 Diabetes Mellitus (2010) (1)
- New insights : Clinical pearis for using incretin mimetios in type 2 diabetes (2007) (1)
- Considerations for treating dyslipidemia in special diabetic populations. (2002) (1)
- 655-P: Improved Outcomes with Diabetes Devices Using Lower-Literacy Teaching Guides in a Center for Underserved Individuals with Type 1 Diabetes (2020) (0)
- Inhibition of Sleep-Induced Growth Hormone Secretion: No Effect on Diabetic Control (1990) (0)
- USC Physician Anne L. Peters Receives American Diabetes Association's Distinguished Clinician Award (2008) (0)
- 1626-P: Differences in Patient-Reported Outcomes (PROs) by Age and Region in Adults with Type 1 Diabetes (T1D) in the SAGE Study (2020) (0)
- Glycemic Index: As Important as Drugs in Diabetes (2015) (0)
- [Major thrombocytopenia induced by heparin. Report of 3 cases]. (1996) (0)
- 135-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Severe Renal Impairment (2020) (0)
- In this issue (2002) (0)
- Combination Oral Agent Therapy in the Treatment of Type 2 Diabetes (2007) (0)
- Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. (2012) (0)
- [Raynaud's phenomenon. Multicenter study of 124 cases]. (1996) (0)
- Use of Glycosylated Hemoglobin Levels for Diagnosing Diabetes Mellitus-Reply (1997) (0)
- ["Penetrating ulcer" of the aorta in a male patient with Takayasu's disease]. (1993) (0)
- [Coexistent psoriasis and systemic lupus erythematosus. A case report]. (2005) (0)
- A piece of my mind. Clinic of tears. (2009) (0)
- Equity in Medical Care for People Living With Diabetes. (2022) (0)
- [Erythema nodosum: what etiologic survey?]. (1998) (0)
- 136-LB: Efficacy and Safety of Sotagliflozin (SOTA) in Patients with Type 2 Diabetes (T2D) and Moderate Renal Impairment (2020) (0)
- Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy (2023) (0)
- Representativeness of Dipeptidyl-Peptidase-4 Inhibitor Cardiovascular Outcomes Trials (2016) (0)
- Characteristics of Adult vs. Childhood-Onset Type 1 Diabetes (T1D) in the T1D Exchange Registry (2018) (0)
- Author response for "Glycemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data" (2020) (0)
- Association connectivites et cancers a propos de 4 observations (2006) (0)
- Responses of somatostatin components to oral glucose in human plasma. (1983) (0)
- 666-P: CGM Access Is the Main Barrier to TIR Use among Providers (2022) (0)
- Ophthalmology in SA Family Practice : CPD (2006) (0)
- CPD Editorial Ophthalmology in SA Family Practice (2006) (0)
- DataBase: Research and Evaluation Results (1998) (0)
- Amici Brief of the National Women's Health Network, et al., in Support of Petition for Writ of Certiorari (2012) (0)
- Ophthalmology in SA Family Practice (2006) (0)
- The Newest Revolution in Diabetes Treatment: Continuous Glucose Sensing (2007) (0)
- Ophthalmology in SA Family Practice CPD Editorial (2006) (0)
- The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy (2021) (0)
- Remarks by Anne Peters (2011) (0)
- The Breton case for regional autonomy: Centuries of struggle in Brittany, France (1986) (0)
- English Peters Corpus (2004) (0)
- Definition of the Question (2016) (0)
- Preface to the German Edition of 2014 (2016) (0)
- Correction to: Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes (2022) (0)
- "Article 24" and "Article 25" (2012) (0)
- Efficacy of sotagliflozin 400 mg/day in 1402 patients with type 1 diabetes treated with any insulin regimen (inTandem 3) (2018) (0)
- Military Operations Abroad Under the German Basic Law (2019) (0)
- Anne-Kathrin Peters (2016) (0)
- The Gentle Globaliser (2022) (0)
- Politikverlust? (2007) (0)
- Glucose fluxes: Primacy of the brain (2004) (0)
- Increased Derived Time in Range is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE. (2023) (0)
- Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients—STAT Study (2018) (0)
- Blue Circle Health: A Novel Patient-Centered Model of Health Care Delivery for Low-Income Patients With Type 1 Diabetes. (2023) (0)
- 25. Linkages between Diabetes Distress and Depressive Symptoms with Glycemic Control Over Time in Adults with Type 1 Diabetes (846-P) (2015) (0)
- 347-OR: The Long-Term Effects of an Intensive Lifestyle Intervention on Medicare Outcomes (2019) (0)
- Diabetes in Women: Pathophysiology and Therapy (2011) (0)
- The modifying role of loneliness on the associations of diurnal cortisol patterns with glycaemia and incident type 2 diabetes (2022) (0)
- Response to the comment on: “Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post‐hoc analysis of the AWARD‐2, ‐4 and ‐5 trials” (2018) (0)
- Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes. (2023) (0)
- 1102-P: Impact of Treatment with Sotagliflozin on the Incidence of Severe Hypoglycemia in Patients with T1D (2020) (0)
- Reduction of Hyperinsulinemia by Glyburide—Scientific Fact or Advertising Fiction? (1992) (0)
- Report from the Scientific Poster Session at the 13th Annual Cardiometabolic Health Congress in Boston, USA, 24–27 October 2018 (2018) (0)
- Brief of Amici Curiae the National Women's Health Network et al in Support of Appellees (2012) (0)
- chorego – stanowisko American Diabetes Association ( ADA ) i European Association for the Study of Diabetes ( EASD ) (2016) (0)
- 2418-PUB: Incident Diabetes Complications among Women with T1D Based on Parity (2019) (0)
- Improved Postprandial Blood Glucose (PPBG) Excursions with Technosphere Inhaled Insulin (TI) Compared with Aspart in T1D Patients—STAT Study (2018) (0)
- 346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon (2021) (0)
- Authors’ reply to Bosco-Lévy and Salvo (2016) (0)
- 964-P: CGM-Tele Monitoring in Older Adults with T1D: Results of a Pilot Study (2019) (0)
- Correction to: Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes (2022) (0)
- A Point-of-Care Interactive Decision Tool Reveals Variance Between Clinicians and Experts in Selecting Among GLP-1 RAs in T2D (2021) (0)
- Considerations for treating dyslipidemia in special diabetic populations (2002) (0)
- Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research (2013) (0)
- 1129-P: Effect of Sotagliflozin Added to Insulin Therapy on Beta-Hydroxybutyrate in Patients with Type 1 Diabetes (2020) (0)
- Challenges in applying diabetes technology to clinical care. (2012) (0)
- 278-OR: ADA Presidents' Select Abstract: Impact of Overnight Blood Glucose on Next-Day Functioning in T1D (2022) (0)
- Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease (2023) (0)
- 665-P: Awareness of Time in Range Varies by Type of Health Care Provider (2022) (0)
- Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes (2019) (0)
- Impact of Overnight Glucose on Next-Day Functioning in Adults With Type 1 Diabetes: An Exploratory Intensive Longitudinal Study. (2023) (0)
- Research: Care Delivery A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach (2021) (0)
- Gender Differences In Coronary Artery Calcification: Observations From An Employer Health Benefits Screening Program (2020) (0)
- 1123-P: Racial Differences in Glycemia and A1C in the Vitamin D and Diabetes (D2d) Study (2022) (0)
- Running a Diabetes Clinic (2006) (0)
- 279-OR: Self-Efficacy, Diabetes Distress, Self-Care, and Blood Glucose: Within-Person Pathways in Adults with T1D (2022) (0)
- Diagnostic and Therapeutic Considerations in Adults with Diabetes Mellitus Case Studies (0)
- Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590–1599 (2019) (0)
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF HYPERANDROGENIC DISORDERS AACE Hyperandrogenism Guidelines (2001) (0)
This paper list is powered by the following services:
Other Resources About Anne L. Peters
What Schools Are Affiliated With Anne L. Peters?
Anne L. Peters is affiliated with the following schools: